Cytokinetics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.About CYTK
Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.
CEORobert I. Blum
CEORobert I. Blum
Employees498
Employees498
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded1997
Founded1997
Employees498
Employees498
CYTK Key Statistics
Market cap7.49B
Market cap7.49B
Price-Earnings ratio-11.92
Price-Earnings ratio-11.92
Dividend yield—
Dividend yield—
Average volume1.92M
Average volume1.92M
High today$63.86
High today$63.86
Low today$61.00
Low today$61.00
Open price$61.15
Open price$61.15
Volume1.44M
Volume1.44M
52 Week high$63.86
52 Week high$63.86
52 Week low$29.31
52 Week low$29.31
CYTK News
Simply Wall St 6d
Have Insiders Sold Cytokinetics Shares Recently?We'd be surprised if Cytokinetics, Incorporated ( ) shareholders haven't noticed that an insider, Edward Kaye, recently sold US$405k worth of stock at US$60.00...
Analyst ratings
81%
of 21 ratingsBuy
81%
Hold
19%
Sell
0%
People also own
Based on the portfolios of people who own CYTK. This list is generated using Robinhood data, and it’s not a recommendation.